The Goldman Sachs Group, Inc. 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-07 4:33 pm Sale |
2022-12-30 | 13G | Puma Biotechnology, Inc. PBYI |
GOLDMAN SACHS GROUP INC GS |
396,136 0.900% |
-1,701,511 (-81.12%) |
Filing |
| 2022-02-08 4:43 pm Purchase |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
GOLDMAN SACHS GROUP INC GS |
2,097,647 5.100% |
2,097,647 (New Position) |
Filing |